1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Aileron Therapeutics Inc (ALRN)
  7. Quote


Aileron Therapeutics Stock Price

-0.0073 (-1.17%)
Volume 483,073
Bid Price 0.63
Ask Price 0.635
News -
Day High 0.6473


52 Week Range


Day Low 0.5999
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aileron Therapeutics Inc ALRN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0073 -1.17% 0.6169 17:00:00
Open Price Low Price High Price Close Price Prev Close
0.63 0.5999 0.6473 0.6169 0.6242
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,425 483,073 $ 0.6204457 $ 299,721 - 0.5862 - 2.33
Last Trade Time Type Quantity Stock Price Currency
16:00:01 443 $ 0.6169 USD


Draw Mode:

Aileron Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.87M 90.57M 71.32M $ - $ - -0.63 -2.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.40%

more financials information »

Aileron Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALRN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.700.720.58620.6534472542,900-0.0831-11.87%
1 Month0.91320.93990.58620.7574384516,125-0.2963-32.45%
3 Months1.201.270.58620.9531503513,862-0.5831-48.59%
6 Months1.251.400.58621.07521,769-0.6331-50.65%
1 Year1.112.330.58621.531,567,747-0.4931-44.42%
3 Years2.192.600.251.37864,125-1.57-71.83%
5 Years13.7515.480.251.55606,728-13.13-95.51%

Aileron Therapeutics Description

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.

Your Recent History
Aileron Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.